PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $63,305,000 | +173.8% | 3,518,906 | +8.5% | 0.01% | +150.0% |
| Q1 2020 | $23,122,000 | -70.0% | 3,242,873 | +0.5% | 0.00% | -60.0% |
| Q4 2019 | $77,054,000 | -10.0% | 3,226,702 | +1.1% | 0.01% | -16.7% |
| Q3 2019 | $85,586,000 | -12.6% | 3,191,127 | -11.6% | 0.01% | -14.3% |
| Q2 2019 | $97,972,000 | -16.8% | 3,611,197 | +6.5% | 0.01% | -22.2% |
| Q1 2019 | $117,693,000 | +55.9% | 3,391,725 | -12.3% | 0.01% | +28.6% |
| Q4 2018 | $75,508,000 | -20.9% | 3,868,234 | +8.0% | 0.01% | 0.0% |
| Q3 2018 | $95,407,000 | -10.7% | 3,582,643 | +26.7% | 0.01% | -22.2% |
| Q2 2018 | $106,836,000 | +7.2% | 2,828,579 | -7.3% | 0.01% | +12.5% |
| Q1 2018 | $99,654,000 | -10.6% | 3,051,305 | +33.3% | 0.01% | -11.1% |
| Q4 2017 | $111,414,000 | -14.1% | 2,288,721 | -4.7% | 0.01% | -18.2% |
| Q3 2017 | $129,724,000 | +10.7% | 2,401,005 | +15.1% | 0.01% | +10.0% |
| Q2 2017 | $117,164,000 | +50.9% | 2,085,838 | +5.3% | 0.01% | +42.9% |
| Q1 2017 | $77,622,000 | +71.6% | 1,980,631 | -1.8% | 0.01% | +75.0% |
| Q4 2016 | $45,242,000 | +0.5% | 2,016,452 | +1.7% | 0.00% | -20.0% |
| Q3 2016 | $45,014,000 | +20.8% | 1,982,425 | +25.5% | 0.01% | +25.0% |
| Q2 2016 | $37,277,000 | +6.2% | 1,579,605 | -8.2% | 0.00% | 0.0% |
| Q1 2016 | $35,085,000 | -49.5% | 1,720,000 | +27.3% | 0.00% | -50.0% |
| Q4 2015 | $69,513,000 | +25.7% | 1,351,054 | +4.1% | 0.01% | +33.3% |
| Q3 2015 | $55,292,000 | -7.2% | 1,297,428 | -0.8% | 0.01% | 0.0% |
| Q2 2015 | $59,597,000 | +24.9% | 1,308,304 | +4.1% | 0.01% | +20.0% |
| Q1 2015 | $47,720,000 | +35.3% | 1,257,103 | +0.9% | 0.01% | +25.0% |
| Q4 2014 | $35,279,000 | +150.7% | 1,245,824 | +123.9% | 0.00% | +100.0% |
| Q3 2014 | $14,071,000 | -8.5% | 556,535 | +5.6% | 0.00% | 0.0% |
| Q2 2014 | $15,385,000 | +268.6% | 527,201 | +227.0% | 0.00% | – |
| Q1 2014 | $4,174,000 | +0.1% | 161,202 | -0.4% | 0.00% | – |
| Q4 2013 | $4,169,000 | +26.8% | 161,929 | +31.8% | 0.00% | – |
| Q3 2013 | $3,287,000 | +38.2% | 122,843 | +26.9% | 0.00% | – |
| Q2 2013 | $2,378,000 | – | 96,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
| PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
| Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
| Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
| HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
| Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
| Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |